These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25003632)

  • 1. Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity.
    Tiradentes RV; Pires JG; Silva NF; Ramage AG; Santuzzi CH; Futuro Neto HA
    Braz J Med Biol Res; 2014 Jul; 47(7):554-9. PubMed ID: 25003632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
    Preskorn SH; Shah R; Neff M; Golbeck AL; Choi J
    J Psychiatr Pract; 2007 Jan; 13(1):5-12. PubMed ID: 17242587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat.
    Sokolowski JD; Seiden LS
    Psychopharmacology (Berl); 1999 Nov; 147(2):153-61. PubMed ID: 10591882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic fluoxetine treatment enhances sympathetic activities associated with abnormality of baroreflex function in conscious normal rats.
    Hong LZ; Huang KF; Hung SW; Kuo LT
    Eur J Pharmacol; 2017 Sep; 811():164-170. PubMed ID: 28629735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors increase sympathetic activity under heavy alcohol exposure in rat models.
    Hu TM; Wu MS; Wu WT; Yang FL; Lee RP
    Life Sci; 2016 Feb; 147():92-6. PubMed ID: 26800785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities.
    Voris JC
    J Clin Psychol; 1999 Jan; 55(1):129-33. PubMed ID: 10100839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antidepressive agents].
    LaBranche S
    Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.
    Liston HL; DeVane CL; Boulton DW; Risch SC; Markowitz JS; Goldman J
    J Clin Psychopharmacol; 2002 Apr; 22(2):169-73. PubMed ID: 11910262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sertraline, paroxetine, fluoxetine and escitalopram on testicular tissue and oxidative stress parameters in rats.
    Erdemir F; Atilgan D; Firat F; Markoc F; Parlaktas BS; Sogut E
    Int Braz J Urol; 2014; 40(1):100-8. PubMed ID: 24642156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline inhibits formalin-induced nociception and cardiovascular responses.
    Santuzzi CH; Futuro Neto HA; Pires JG; Gonçalves WL; Tiradentes RV; Gouvea SA; Abreu GR
    Braz J Med Biol Res; 2012 Jan; 45(1):43-8. PubMed ID: 22086464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
    Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.
    Seo KK; Kim SC; Lee MY
    J Urol; 2001 Jun; 165(6 Pt 1):2110-4. PubMed ID: 11371937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Medications for DSM-5 PTSD in Routine VA Practice.
    Shiner B; Leonard CE; Gui J; Cornelius SL; Schnurr PP; Hoyt JE; Young-Xu Y; Watts BV
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33049805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.